Defining Outcomes for -cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop

Author(s):: Rickels, M.R.; Stock, P.G.; Koning, E.J.P. de (0000-0002-1232-7022); Piemonti, L.; Pratschke, J.; Alejandro, R.; Bellin, M.D.; Berney, T.; Choudhary, P.; Johnson, P.R.; Kandaswamy, R.; Kay, T.W.H.; Keymeulen, B.; Kudva, Y.C.; Latres, E.; Langer, R.M.; Lehmann, R.; Ludwig, B.; Markmann, J.F.; Marinac, M.; Odorico, J.S.; Pattou, F.; Senior, P.A.; Shaw, J.A.M.; Vantyghem, M.C.; White, S.

Published: 2018
Publication type: Article / Letter to editor

Date issued: 2018-09-30
Language: English
Is part of: Transplantation (2018), Vol. 102, no. 9, p. 1479-1486
hdl: 1887/86705
doi: 10.1097/TP.0000000000002158
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408213/pdf/nihms-1015474.pdf